Psilocybin rewires synapses in one brain layer but hallucinations come from somewhere else

Key Findings

🔬 LSD finally mapped in living human brains

• Using simultaneous PET-MRI in 7 healthy volunteers, researchers showed LSD occupies serotonin receptors with high affinity, increases global cerebral blood flow, and decreases global brain connectivity — with connectivity changes running opposite to blood flow changes.
• An unusual anticlockwise hysteresis loop between blood drug levels and subjective effects suggests the brain's response to LSD outlasts the drug itself, pointing to mechanisms beyond simple receptor occupancy.

🌿 Ayahuasca disrupts fear memories and reshapes synapses within 24 hours

• In rats, a single oral dose of ayahuasca given before fear memory retrieval significantly reduced subsequent freezing behavior and increased dendritic spine density across multiple hippocampal regions and the prelimbic cortex within 24 hours.
• Critically, the timing mattered: ayahuasca had to be given during the reconsolidation window to produce behavioral effects, and neurogenesis was unaffected — suggesting rapid synaptic remodeling, not new cell growth, drives the fear-reduction outcome.

🍄 Oregon's psilocybin service centers: what actually happens when you call

• A mystery shopper study contacted Oregon psilocybin service centers — the first US state to permit supervised psilocybin outside medical settings — posing as prospective clients with psychiatric histories to document how staff communicated about safety, eligibility, and cost.
• The study examined a real-world gap: a nonmedical wellness model is now operating at scale, and what people with mental health histories are actually told when they inquire remains largely undocumented.

💊 Ibogaine rewires neurons by stressing their metabolism first

• Lab and animal studies found that ibogaine rapidly suppressed mitochondrial function and energy production in cortical neurons within minutes, followed by a marked rebound in energy output roughly 20 hours later — a pattern consistent with metabolic preconditioning.
• Protein profiling in mice showed this stress-then-recovery sequence coincided with activation, then suppression, then reactivation of synaptic plasticity pathways over 72 hours, suggesting ibogaine may reopen a neurodevelopmental repair window through transient metabolic disruption.

💑 Psychedelic users and relationship quality: not what the drug-use literature predicts

• Using data from the National Couples' Health and Time Study, people who reported past-year psychedelic use looked similar to non-drug users on most relationship measures and reported fewer negative interactions and lower odds of perpetrating intimate partner abuse than people who reported stimulant or opioid use.
• The one exception: psychedelic users reported lower relationship commitment than non-users. The study is observational, so selection effects — who chooses psychedelics versus other drugs — cannot be ruled out.

🧪 Sugar molecule in magic mushrooms shows antidepressant signals — in mice

• Researchers isolated alpha,alpha-trehalose, a common sugar found in Psilocybe cubensis mushrooms, and tested it in standard rodent anxiety and depression behavioral models. It produced anxiolytic- and antidepressant-like effects, with computational docking suggesting involvement of a serotonin receptor subtype linked to mood regulation.
• This is preclinical only — but it raises the possibility that therapeutic effects from psilocybin mushrooms involve more than just psilocybin itself.